ANTHROGENESIS CORPORATION
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Jan 25, 2018 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,042 Total Citation Count
- Mar 26, 2002 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0021,378 METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLSDec 30, 15Jan 25, 18[A61K, C12N]
2017/0000,779 Modulation of Stem Cell and Progenitor Cell Differentiation, Assays, And Uses ThereofFeb 08, 16Jan 05, 17[A61K]
2003/0187,515 Collagen biofabric and methods of preparing and using the collagen biofabricMar 26, 02Oct 02, 03[A61F]
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0023,926 TREATMENT OF RADIATION INJURY USING AMNION DERIVED ADHERENT CELLSAbandonedJul 13, 12Jan 22, 15[A61K]
2012/0201,787 TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLSAbandonedDec 15, 11Aug 09, 12[A61K, A61P]
2012/0171,180 COMPOSITIONS COMPRISING AMNION DERIVED ADHERENT CELLS AND PLATELET-RICH PLASMAAbandonedDec 29, 11Jul 05, 12[A61K, A61P]
2010/0172,830 Extraembryonic Tissue cells and method of use thereofAbandonedFeb 08, 08Jul 08, 10[A61K, C12N]
2007/0038,298 Repair of tympanic membrane using placenta derived collagen biofabricAbandonedJun 29, 06Feb 15, 07[A61F]
2004/0028,660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromesAbandonedMay 30, 03Feb 12, 04[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.